BioMarin Pharmaceutical Inc. (NASDAQ: BMRN)
| Pre-Market | Intra-Day | After-Hours |
|---|---|---|
| 60.55 (-0.03 / -0.05%) | 60.02 (-0.56 / -0.92%) | 59.40 (-0.62 / -1.03%) |
| 31-Jul 09:16 | 31-Jul 16:00 | 31-Jul 17:15 |
Sector: Healthcare || Industry: Biotechnology
| Previous Close | 60.58 | Year Low | 49.26 |
| Open | 60.42 | Year High | 66.28 |
| Day Low | 58.92 | Price Avg 50 | 57.07 |
| Day High | 60.80 | Price Avg 200 | 56.25 |
| Volume | 2.32 M | Market Cap | 11.6 B |
News
Analysis
| Symbol | 1D | 5D | 1M | 3M | 6M | 1Y |
|---|---|---|---|---|---|---|
| BMRN | -0.92 | 1.32 | 4.89 | 11.33 | 6.15 | 3.75 |
Earnings
| Date | Time | Symbol | company_name | Period | Metric | Estimate | Actual | Surprise | YrAgo | Growth | sector_industry |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 05/04/2026 | AMC | BMRN | Biomarin Pharmaceutical | Q1 2026 | EPS | 0.79 | 0.76 | -3.80 | 1.13 | -32.70 | |
| 05/04/2026 | AMC | BMRN | Biomarin Pharmaceutical | Q1 2026 | REV | 755.61 M | 766.21 M | 1.40 | 745.15 M | 2.83 | |
| 02/23/2026 | AMC | BMRN | BioMarin Pharmaceutical | Q4 2025 | EPS | 0.63 | 0.46 | -26.98 | 0.92 | -50.00 | |
| 02/23/2026 | AMC | BMRN | BioMarin Pharmaceutical | Q4 2025 | REV | 827.97 M | 875.00 M | 5.68 | 747.00 M | 17.14 | |
| 10/27/2025 | AMC | BMRN | BioMarin Pharmaceutical | Q3 2025 | EPS | 0.37 | 0.12 | -67.57 | 0.91 | -86.80 | |
| 10/27/2025 | AMC | BMRN | BioMarin Pharmaceutical | Q3 2025 | REV | 780.63 M | 776.13 M | -0.58 | 745.74 M | 4.08 | |
| 08/04/2025 | AMC | BMRN | Biomarin Pharmaceutical | Q2 2025 | EPS | 0.85 | 1.44 | 69.41 | 0.96 | 50.00 | |
| 08/04/2025 | AMC | BMRN | Biomarin Pharmaceutical | Q2 2025 | REV | 760.39 M | 825.41 M | 8.55 | 712.03 M | 15.92 |
Outlooks
| Date | Time | Symbol | Company | Period | Metric | Estimate | Outlook | Previous | Catalyst | list_link | eps_est | rev_est | cur_midpoint | pre_midpoint | Growth * | yrago_growth | pre_growth | company_sector | company_industry | ref_id | chart_code | history_code | sector_industry |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 02/23/2026 | 04:03 PM | BMRN | BioMarin Pharmaceutical | FY 2026 | EPS | $4.41 | $4.95 ~ $5.15 | 0.00 | 5.05 | 14.51 | 44,517 | ||||||||||||
| 02/23/2026 | 04:03 PM | BMRN | BioMarin Pharmaceutical | FY 2026 | REV | $3.51 B | $3.33 B ~ $3.43 B | 0.00 | 3,375.00 | -3.76 | 44,517 | ||||||||||||
| 01/12/2026 | 04:05 PM | BMRN | BioMarin Pharmaceutical | FY 2025 | REV | $3.18 B | $3.20 B | $3.15 B ~ $3.20 B | 0.00 | 3,200.00 | 3,175.00 | 0.76 | 0.79 | 42,924 |
Ratings
| Date | Symbol | Analyst Firm | Rating Current | Rating Previous | Analyst Action |
|---|---|---|---|---|---|
| 05/22/2026 | BMRN | Canaccord Genuity | Buy | Buy | Maintain |
| 05/19/2026 | BMRN | B of A Securities | Buy | Buy | Maintain |
| 05/18/2026 | BMRN | HC Wainwright & Co. | Neutral | Neutral | Maintain |
| 05/07/2026 | BMRN | Canaccord Genuity | Buy | Buy | Maintain |
| 05/05/2026 | BMRN | HC Wainwright & Co. | Neutral | Neutral | Maintain |
| 05/05/2026 | BMRN | Evercore ISI Group | Outperform | Outperform | Maintain |
| 05/05/2026 | BMRN | RBC Capital | Sector Perform | Sector Perform | Maintain |
| 05/05/2026 | BMRN | Morgan Stanley | Overweight | Overweight | Maintain |
| 05/05/2026 | BMRN | Bernstein | Outperform | Outperform | Maintain |
| 03/11/2026 | BMRN | B of A Securities | Buy | Buy | Maintain |
Dividends
| Date | Symbol | Company | Type | Value | Yield | Record Date | Exch Date | Pay Date | Notes |
|---|
Sign-Up to see the full list of CATALYSTS in the Calendars
